Bank of America Securities Reaffirms Their Buy Rating on Reliance Industries Limited (RELIANCE)
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Salgaonkar is ranked #1235 out of 9622 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Reliance Industries Limited with a INR1,546.20 average price target, which is a 2.03% upside from current levels. In a report released on June 25, Citi also maintained a Buy rating on the stock with a INR1,690.00 price target.
The company has a one-year high of INR1,608.95 and a one-year low of INR1,115.55. Currently, Reliance Industries Limited has an average volume of 858.6K.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
6 hours ago
- Business Upturn
IKS Health Reports Robust Q1 FY26 Results with 16% Year-over-Year Revenue Growth and 59% Year-over-Year PAT Increase
By Business Wire India Published on July 31, 2025, 23:11 IST Inventurus Knowledge Solutions Limited (NSE: IKS), a technology-enabled healthcare solutions provider, today announced strong growth in Q1 FY26. IKS Health, a care enablement platform focused on supporting physician enterprises primarily in the US, reported its financial results for the quarter ended June 30, 2025. Business Wire India Revenue growth in Q1 16% YoY in INR, 13% YoY in USD Q1 EBITDA up 36% YoY; 5% QoQ PAT up 59% YoY; 3% QoQ Inventurus Knowledge Solutions Limited (NSE: IKS), a technology-enabled healthcare solutions provider, today announced strong growth in Q1 FY26. IKS Health, a care enablement platform focused on supporting physician enterprises primarily in the US, reported its financial results for the quarter ended June 30, 2025. 'Our performance this quarter reflects the continued momentum in our business and the stickiness of our integrated tech-led care enablement platform built on strong client relationships, scalable solutions, and disciplined execution,' said Sachin K. Gupta, Founder & Global CEO, IKS Health. 'The sustained revenue growth at 16% and improvement of EBITDA margin for the combined entity to 32% demonstrates the impact of our technology-led care enablement platform and global delivery capabilities. As we move forward, our focus remains on deepening client value, investing in innovation, and scaling our platform to address the evolving needs of the healthcare ecosystem.' Nithya Balasubramanian, CFO, IKS Health, said, 'We delivered a strong financial performance in Q1 FY26, driven by consistent revenue growth and continued focus on operational efficiency. Our EBITDA margin improvement reflects disciplined cost management, scalability of our platform, and prudent capital allocation. As we move ahead, we remain committed to sustaining healthy margins while strategically investing in capabilities that drive long-term value creation.' Key Financial Highlights: Q1FY26 ended on June 30, 2025 Revenue at INR 7,401 million (15.6% YoY / + 2.2% QoQ growth) EBITDA at INR 2,378 million at 32.1% of revenue (36.3% YoY / +5.1% QoQ growth) PAT at INR 1,515 million at 20.5% of revenue (58.7% YoY / 2.5% QoQ growth) Adjusted PAT at INR1,682 million at 22.7% of revenue (51.4% YoY / 2.2% QoQ growth) Business Highlights: IKS Health continues to expand its reach and impact through strategic partnerships. The following highlights key collaborations, including both new alliances and the expansion of existing relationships, that demonstrate the company's commitment to driving financial outcomes, enabling growth, and enhancing clinical efficiencies for healthcare providers. Mission Community Hospital: New partnership to drive financial outcomes and accountability with end-to-end revenue cycle across the hospital acute care and ambulatory surgery spaces Bicycle Health: New partnership leveraging IKS to manage revenue cycle, enabling rapid growth and scale of the virtual network OrthoNY: Expanded partnership to introduce IKS Virtual Clinical Assistant at a growing specialty network to take on administrative tasks and support clinical efficiencies in addition to existing RCM services. A top 5 Health System: Expanded partnership for coding to drive revenue performance and mitigate operational inefficiencies. Recognition & Awards IKS Health received the below notable recognitions: ET HRWorld Exceptional Employee Experience – Large Scale Award BW CFO Finance & Strategy Excellence Awards Excellence in Mergers and Acquisitions Award – Gold (Organizational Category) Best Woman CFO, Nithya Balasubramanian (Individual Category) Safe Harbour Certain statements in this release concerning our future growth prospects may be seen as forward-looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. It is not possible to undertake to update any such statement that may have been made from time to time. Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same. Ahmedabad Plane Crash Business Wire India, established in 2002, India's premier media distribution company ensures guaranteed media coverage through its network of 30+ cities and top news agencies.
Yahoo
7 hours ago
- Yahoo
Bank of America Securities Reiterated a Buy Rating on Oddity Tech (ODD)
Oddity Tech Ltd. (NASDAQ:ODD) is one of the . On July 16, Anna Lizzul from Bank of America Securities reiterated a Buy rating on Oddity Tech Ltd. (NASDAQ:ODD) with a price target of $80. The analyst highlighted the company's strong market position and growth potential as driving factors behind her bullish sentiment. She noted that the company uses a proprietary technology for product recommendations, which helps it benefit from the growing shift to online beauty sales. Lizzul noted Oddity Tech Ltd.'s (NASDAQ:ODD) direct-to-consumer model as one of the key strategic edges. A close up of a customer browsing a selection of beauty and personal care products online. Moreover, its brands, including Il Makiage and SpoiledChild, show strong momentum on search channels, indicating that they are expected to remain popular. On top of this, the company also plans to launch new brands and expand internationally. Oddity Tech Ltd. (NASDAQ:ODD) operates a tech platform in the beauty and wellness sector, focusing on personalized products. While we acknowledge the potential of ODD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
8 hours ago
- Yahoo
BofA Reiterates a Buy Rating on YPF Sociedad Anónima (YPF)
YPF Sociedad Anónima (NYSE:YPF) is one of the most oversold energy stocks to buy right now. On July 1, Bank of America Securities analyst Leonardo Marcondes reiterated a Buy rating on YPF Sociedad Anónima (NYSE:YPF) and set a price target of $42.00. An oil platform in the North Sea, standing tall and proud against a backdrop of choppy waters. On July 22, Moody's Ratings upgraded YPF Sociedad Anónima's (NYSE:YPF) senior unsecured and secured notes ratings to 'B2' from 'Caa1', reporting a stable outlook. The upgrade includes the Corporate Family Rating and suggests optimism for YPF Sociedad Anónima's (NYSE:YPF) financial stability, potentially boosting its attractiveness to investors and enhancing its reputation. YPF Sociedad Anónima (NYSE:YPF) explores, produces, and distributes oil and gas. The company operates in the following segments: Upstream, Gas and Power, Downstream, Central Administration and Other. While we acknowledge the potential of YPF as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
